{"id":"ademetionine-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ademetionine (also known as S-adenosyl methionine or SAM) is an endogenous compound that serves as the primary methyl donor in cells. It participates in critical methylation reactions involving proteins, lipids, and nucleic acids, and supports hepatocyte membrane integrity and regeneration. By restoring depleted SAM levels, it enhances liver function and reduces cholestasis and hepatic damage.","oneSentence":"Ademetionine is a methyl donor that replenishes cellular S-adenosylmethionine (SAM) levels to support methylation reactions and hepatic function.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:29:28.638Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Liver disease and cholestasis"},{"name":"Hepatic dysfunction"},{"name":"Drug-induced liver injury"}]},"trialDetails":[{"nctId":"NCT07495995","phase":"PHASE2","title":"Single-Center Phase II Double-Blind Trial of SAMe to Prevent Liver Cancer in MASLD-Related Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-04-15","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","enrollment":94},{"nctId":"NCT06258525","phase":"PHASE2","title":"SAMe in Prevention of Oxaliplatin-associated Liver Injury","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-03","conditions":"Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer","enrollment":30},{"nctId":"NCT06922669","phase":"NA","title":"Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-06-24","conditions":"Drug Induced Liver Injury","enrollment":232},{"nctId":"NCT04240990","phase":"NA","title":"Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnutrition (TB-Speed SAM)","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2019-11-04","conditions":"Tuberculosis, Severe Acute Malnutrition","enrollment":603},{"nctId":"NCT04250259","phase":"PHASE2","title":"SAMe Trial for Patients With Alcoholic Cirrhosis","status":"RECRUITING","sponsor":"Indiana University","startDate":"2020-10-22","conditions":"Alcoholic Cirrhosis","enrollment":196},{"nctId":"NCT07068191","phase":"NA","title":"Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly","status":"RECRUITING","sponsor":"Phenomen Pharma","startDate":"2025-06-19","conditions":"Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD), Hepatomegaly, Nonalcoholic Fatty Liver (NAFL)","enrollment":90},{"nctId":"NCT05363020","phase":"PHASE4","title":"S-Asenosyl-L-Methionine vs Placebo for Osteoarthritis of the Hands","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2022-08-17","conditions":"Osteoarthritis Hand","enrollment":40},{"nctId":"NCT03766048","phase":"NA","title":"LAparoscopic Preventive PRErectal Mesh","status":"UNKNOWN","sponsor":"University Hospital, Lille","startDate":"2019-09-11","conditions":"Urogenital Prolapse","enrollment":834},{"nctId":"NCT04313348","phase":"NA","title":"Patient-centered Mobile Technology Interventions to Improve Maternal Health in Uganda","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2020-08-01","conditions":"Maternal Child Health","enrollment":170},{"nctId":"NCT03721679","phase":"PHASE1, PHASE2","title":"Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1","status":"TERMINATED","sponsor":"Oncovir, Inc.","startDate":"2018-09-25","conditions":"Solid Cancer","enrollment":7},{"nctId":"NCT04623034","phase":"PHASE1","title":"Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine","status":"COMPLETED","sponsor":"MSI Methylation Sciences, Inc.","startDate":"2013-04-17","conditions":"Major Depressive Disorder","enrollment":34},{"nctId":"NCT02592434","phase":"PHASE3","title":"Efficacy Study Of Tofacitinib In Pediatric JIA Population","status":"COMPLETED","sponsor":"Pfizer","startDate":"2016-06-10","conditions":"Juvenile Idiopathic Arthritis","enrollment":225},{"nctId":"NCT03932474","phase":"NA","title":"EVALUATION OF EFFICACY OF SAMEUP IN SUBJECTS WITH DEPRESSION SYMPTOMS: A RANDOMIZED STUDY","status":"COMPLETED","sponsor":"Nutrilinea srl","startDate":"2018-09-17","conditions":"Depressive Symptoms","enrollment":90},{"nctId":"NCT03863002","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure","status":"UNKNOWN","sponsor":"Tianjin Weikai Bioeng., Ltd.","startDate":"2019-10-01","conditions":"Liver Failure, Acute on Chronic","enrollment":45},{"nctId":"NCT00513461","phase":"PHASE2","title":"Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection","status":"COMPLETED","sponsor":"Chao Family Comprehensive Cancer Center","startDate":"2007-10","conditions":"Adult Primary Liver Cancer, Hepatitis C Infection","enrollment":110},{"nctId":"NCT00070941","phase":"PHASE2, PHASE3","title":"SAM-e for the Treatment of Depression in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2003-07","conditions":"Parkinson's Disease, Depression","enrollment":29},{"nctId":"NCT01912196","phase":"PHASE2","title":"Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)","status":"COMPLETED","sponsor":"MSI Methylation Sciences, Inc.","startDate":"2013-10","conditions":"Major Depressive Disorder (MDD)","enrollment":376},{"nctId":"NCT01320527","phase":"PHASE2","title":"A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-08","conditions":"Alzheimer's Disease, Mild Cognitive Impairment","enrollment":135},{"nctId":"NCT01754714","phase":"PHASE3","title":"Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group","status":"COMPLETED","sponsor":"Abbott","startDate":"2012-12","conditions":"Non Alcoholic Fatty Liver Disease","enrollment":108},{"nctId":"NCT02200029","phase":"PHASE3","title":"Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption","status":"COMPLETED","sponsor":"Abbott","startDate":"2014-06","conditions":"Intrahepatic Cholestasis Associated With Alcoholic Liver Disease","enrollment":75},{"nctId":"NCT00093847","phase":"PHASE2","title":"Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2004-05","conditions":"Depression","enrollment":73},{"nctId":"NCT01998620","phase":"PHASE4","title":"Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis","status":"UNKNOWN","sponsor":"Zhejiang Hisun Pharmaceutical Co. Ltd.","startDate":"2013-11","conditions":"Hepatitis B, Cholestasis","enrollment":240},{"nctId":"NCT01579656","phase":"PHASE1","title":"Effect of Flax, Poppy, Sesame & Salba on Postprandial Blood Glucose Response, Vascular, Appetite & Sensory Parameters","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2011-02","conditions":"Cardiovascular Diseases","enrollment":21},{"nctId":"NCT00475176","phase":"PHASE2","title":"S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2007-05","conditions":"Chronic Hepatitis C","enrollment":24},{"nctId":"NCT00722124","phase":"PHASE2, PHASE3","title":"S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-09","conditions":"Tobacco Dependence","enrollment":150},{"nctId":"NCT00851981","phase":"PHASE2","title":"Randomized, Controlled Trial of S-adenosylmethionine in Alcoholic Liver Disease","status":"COMPLETED","sponsor":"Loma Linda University","startDate":"2008-10","conditions":"Alcoholic Hepatitis","enrollment":60},{"nctId":"NCT00528710","phase":"PHASE2","title":"Efficacy of S-Adenosylmethionine in Fibromyalgia","status":"COMPLETED","sponsor":"Deakin University","startDate":"2006-11","conditions":"Fibromyalgia Syndrome","enrollment":70}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BACTERAEMIA"},{"count":1,"reaction":"DEATH"},{"count":1,"reaction":"HAEMOLYSIS"},{"count":1,"reaction":"PNEUMONIA"},{"count":1,"reaction":"PORTAL VEIN THROMBOSIS"}],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ademetionine 1","genericName":"Ademetionine 1","companyName":"Zhejiang Hisun Pharmaceutical Co. Ltd.","companyId":"zhejiang-hisun-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ademetionine is a methyl donor that replenishes cellular S-adenosylmethionine (SAM) levels to support methylation reactions and hepatic function. Used for Liver disease and cholestasis, Hepatic dysfunction, Drug-induced liver injury.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}